Biotech COL - Clinical Operations Leader Parexel Employee Review

4.0
17 Nov 2025
Recommend
CEO approval
Business outlook

Pros

Healthy PTO / Clear training / Solid resources / Open communication

Cons

All depends on how good your line manager is - They need to put you in situations where you can succeed. Staffing can be low, or the company will try to save a buck by overworking with you.

avatar
Parexel Response
6mo
Thank you for sharing your thoughtful feedback as a Clinical Operations Leader. Your insight into the importance of line managers is valuable. We recognize that leadership plays a crucial role in setting teams up for success. We're continuously investing in leadership development with our Managers Matter Program and New Manager Training to reach consistent support across all departments. Regarding staffing and workload concerns, we understand the challenges that can arise in our dynamic industry. We strive to provide flexibility and empowerment for each of our employees to integrate work into their lives as well as possible. If you'd like to discuss your specific situation, please contact me at Tom.McGoldrick@Parexel.com.

Explore other reviews about Parexel

5.0
16 June 2026
Recommend
CEO approval
Business outlook

Pros

Well trained managers that empower you, truly listen to you, and only do well if YOU do well/ they provide resources and definitely offer development opportunities to those who want them AND have demonstrated they can maintain their scoped, regular duties at a high level of quality while working on special development projects Also unlimited RTO in US

Cons

no bonuses and too much focus/emphasis on how many years with *Parexel*, as opposed to how many years total you have been in the industry (ex doing site management at another CRO or Sponsor group )

1.0
25 June 2026
Recommend
CEO approval
Business outlook

Pros

The only pro is that they offer remote work.

Cons

I would give zero stars if I could, but since I can’t, I’m forced to give one. They seem to have layoffs almost every year. Their US-based pharmacovigilance team was also affected in 2024 and 2025. It really feels like a hire-and-fire culture.

See reviews by: Helpful|Rating|Date|All